We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-0.01%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$170M
AUM Growth
-$3.54M
Cap. Flow
-$1.18M
Cap. Flow %
-0.69%
Top 10 Hldgs %
23.13%
Holding
180
New
28
Increased
33
Reduced
64
Closed
37

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$2.22M
2
LYB icon
LyondellBasell Industries
LYB
+$1.49M
3
CB icon
Chubb
CB
+$1.46M
4
DLTR icon
Dollar Tree
DLTR
+$1.45M
5
AMGN icon
Amgen
AMGN
+$1.17M

Top Sells

Rank Stock Value
1
PB icon
Prosperity Bancshares
PB
+$2.95M
2
ON icon
ON Semiconductor
ON
+$1.24M
3
MRK icon
Merck
MRK
+$1.23M
4
FISV
Fiserv Inc
FISV
+$1.22M
5
AXP icon
American Express
AXP
+$1.09M

Sector Composition

Rank Sector Weight
1 Industrials 22.11%
2 Healthcare 19.78%
3 Consumer Staples 14.05%
4 Financials 9.51%
5 Technology 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INVH icon
76
Invitation Homes
INVH
$16.3B
$879K 0.52%
28,144
-2,175
-7% -$68.2K
ENB icon
77
Enbridge
ENB
$106B
$848K 0.5%
22,225
-1,350
-6% -$53K
MMM icon
78
3M
MMM
$84.9B
$847K 0.5%
9,636
-120
-1% -$11.3K
AMZN icon
79
Amazon
AMZN
$2.68T
$826K 0.48%
8,000
+1,100
+16% +$106K
VRTX icon
80
Vertex Pharmaceuticals
VRTX
$130B
$780K 0.46%
2,475
+1,525
+161% +$457K
MLM icon
81
Martin Marietta Materials
MLM
$36B
$763K 0.45%
+2,150
New +$754K
GSK icon
82
GSK
GSK
$100B
$757K 0.44%
21,275
+75
+0.4% +$2.62K
ALK icon
83
Alaska Air
ALK
$4.45B
$746K 0.44%
+17,775
New +$834K
AR icon
84
Antero Resources
AR
$11.9B
$728K 0.43%
31,550
-2,850
-8% -$75.1K
ETN icon
85
Eaton
ETN
$152B
$720K 0.42%
4,200
– –
VZ icon
86
Verizon
VZ
$214B
$691K 0.41%
17,759
-56
-0.3% -$2.21K
SON icon
87
Sonoco
SON
$4.77B
$671K 0.39%
+11,000
New +$652K
SBUX icon
88
Starbucks
SBUX
$110B
$650K 0.38%
6,245
– –
APD icon
89
Air Products & Chemicals
APD
$64.7B
$632K 0.37%
+2,200
New +$642K
FLR icon
90
Fluor
FLR
$7.23B
$631K 0.37%
+20,400
New +$702K
LIN icon
91
Linde
LIN
$213B
$631K 0.37%
+1,775
New +$594K
GIS icon
92
General Mills
GIS
$19.6B
$630K 0.37%
7,375
-750
-9% -$59.9K
CL icon
93
Colgate-Palmolive
CL
$69.4B
$623K 0.37%
8,288
-550
-6% -$40.9K
ROL icon
94
Rollins
ROL
$16.2B
$623K 0.37%
+16,600
New +$599K
INMD icon
95
InMode
INMD
$856M
$614K 0.36%
+19,225
New +$658K
CFR icon
96
Cullen/Frost Bankers
CFR
$10.1B
$598K 0.35%
5,675
+150
+3% +$18.7K
APA icon
97
APA Corp
APA
$16.6B
$587K 0.34%
16,275
+5,575
+52% +$224K
TGT icon
98
Target
TGT
$70.1B
$584K 0.34%
3,525
-2,625
-43% -$432K
REXR icon
99
Rexford Industrial Realty
REXR
$8.61B
$579K 0.34%
9,700
-750
-7% -$44.9K
BA icon
100
Boeing
BA
$166B
$555K 0.33%
2,613
– –
2 3
4
5 6

Similar funds

GFP
Guardian Financial Partners Orange, California $257M AUM 19.03% 1-Year Est. Return
UI
Untitled Investments New York $257M AUM 15.31% 1-Year Est. Return
HWA
HMV Wealth Advisors Shreveport, Louisiana $257M AUM 26.62% 1-Year Est. Return
LGW
Leslie Global Wealth Itasca, Illinois $257M AUM 23.12% 1-Year Est. Return
TCG
Transcendent Capital Group Edmond, Oklahoma $257M AUM 25.68% 1-Year Est. Return
6F
626 Financial Portage, Michigan $257M AUM 22.23% 1-Year Est. Return
MCP
Miller Capital Partners Troy, Michigan $257M AUM
BWM
Birchcreek Wealth Management Miami Township, Ohio $257M AUM 34.72% 1-Year Est. Return

New England Research & Management's Q1 2023 Portfolio in Review

As of Q1 2023, New England Research & Management held 180 positions worth $170M, down 2% from $174M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management's Q1 2023 filing shows 28 new, 33 increased, 64 reduced and 37 closed positions. Its largest new stake was Charles Schwab: 30,305 shares worth $1.59M. The largest sale was Prosperity Bancshares, an estimated $2.95M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Staples.

  • New England Research & Management's largest Q1 2023 buy was Charles Schwab: 30,305 shares worth $1.59M.
  • New England Research & Management added most to Amgen in Q1 2023, an estimated $1.17M increase.
  • New England Research & Management's biggest Q1 2023 reduction was Merck, cutting an estimated $1.23M.
  • New England Research & Management fully exited Prosperity Bancshares in Q1 2023, selling an estimated $2.95M.
  • New England Research & Management's ten largest holdings make up 23% of its $170M portfolio in Q1 2023.
  • New England Research & Management opened 28 new positions and closed 37 in Q1 2023.
  • New England Research & Management's portfolio value fell 2% quarter-over-quarter to $170M.

Based on New England Research & Management's 13F filing for Q1 2023, filed 6 Apr 2023.